Results 51 to 60 of about 24,284 (163)

Type I and type III collagen immunoexpression in rabbit skin biopsy samples treated with rosuvastatin gel and autologous platelet-rich plasma [PDF]

Acta Cirúrgica Brasileira
Purpose: To evaluate whether the joint use of autologous platelet-rich plasma (aPRP) and rosuvastatin (RSV) in biopsies of dermal wounds induced in rabbits results in an additive effect on the immunoexpression of collagens type I and III, optimizing the ...
Cristoffer da Silva Santana, Maria Rosa Santos Breda, Yuri Ferreira Vicentini, Sérgio Alexandre Alcantara dos Santos, Luis Antonio Justulin Jr, Anthony Cesar de Souza Castilho, Gisele Alborghetti Nai, Cecília Laposy Santarém   +7 more
doaj   +1 more source

Evaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial

BMC Nutrition, 2022
Background Dyslipidemia is a prominent cause of cardiovascular disease as it leads to inflammation and plaque deposition within arteries. Treatment includes lifestyle modifications and lipid-lowering medications.
Ali Tavan, Saam Noroozi, Bardia Zamiri, Reza Gholchin Vafa, Mohammadhossein Rahmani, Mohammadjavad Mehdizadeh Parizi, Amin Ahmadi, Reza Heydarzade, Mohammad Montaseri, Seyed Ali Hosseini, Javad Kojuri   +10 more
doaj   +1 more source

Effects of short-term atorvastatin use in patients with calcium stones: A randomized placebo-controlled clinical trial [PDF]

Investigative and Clinical Urology, 2019
Purpose: A few experimental and observational studies have reported that atorvastatin prevents calcium oxalate stone formation. Our study is the first to investigate the effect of atorvastatin on 24-hour urinary metabolites, urinary malondialdehyde (U ...
Fatemeh Taheri, Maryam Taheri, Abbas Basiri, Alireza Khoshdel, Fariba Samadian, Sanaz Tavasoli   +5 more
doaj   +1 more source

Genetic Polymorphisms and Statin-Associated Side Effects: The Role of SLCO1B1 and Additional Risk Factors

Southeastern European Medical Journal
Statins are first-line agents for managing dyslipidemia, primarily prescribed to reduce low-density lipoprotein cholesterol (LDL-C) and prevent atherosclerotic cardiovascular disease (ASCVD).
Romana Marušić, Tatjana Bačun, Dunja Šojat, Saška Marczi   +3 more
doaj   +1 more source

Short-Term Therapy with High Dose Atorvastatin in Patients with Coronary Artery Disease Can Reduce Inflammatory Process [PDF]

Acta Medica Iranica, 2010
Coronary heart disease is the leading cause of death and disability in adults. The association between acute coronary syndrom (ACS) and elevated serum high sensitivity c-reactive protein (hsCRP) suggests that chronic inflammation of the coronary arterial
Vida Nesar Hossein, Keivan Yosef Nejad, Fatemeh Abdollahian   +2 more
doaj   +1 more source

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?

Arquivos Brasileiros de Cardiologia, 2018
Background: Long-term safety, effectiveness and criteria for treatment with statins in children are still unclear in clinical practice. There is very limited evidence for the use of medication to treat children with dyslipidemia secondary to obesity who ...
Graciane Radaelli, Grasiele Sausen, Claudia Ciceri Cesa, Vera Lucia Portal, Lucia Campos Pellanda   +4 more
doaj   +1 more source

Effects of exercise on the cognition of older women treated with lovastatin

Biomédica: revista del Instituto Nacional de Salud, 2018
Introduction: The deterioration of cognition is highly predominant in older adults. Objective: The aim of this study was to analyze the effects of a walking program on the cognition and blood concentration of lipids in women over 60 years of age who were
Edgardo Molina-Sotomayor, Rocío Arreguín-Moreno, Fernando Rodríguez-Rodríguez, Francisco Pradas, Juan Antonio León, José Antonio González-Jurado   +5 more
doaj   +1 more source

Antimicrobial Potential of Hydroxymethylglutaryl-Coa Reductases Inhibitors

The 1st International Electronic Conference on Clinical Medicine, 2021
Hélida Maravilha Dantas e Sousa Almeida, Igor de Sousa Oliveira, Sávio Benvindo Ferreira   +2 more
openaire   +1 more source

Statins as a possible factor affecting fluoroquinolone resistance of coagulase-negative in the conjunctiva: a case-control study [PDF]

Kosin Medical Journal
Background Conjunctival bacterial flora is a common cause of endophthalmitis after ophthalmic procedures. This study investigated the conjunctival bacterial flora, especially coagulase-negative Staphylococcus (CoNS), and their antibiotic sensitivity in ...
Yoo Rha Hong, Chi Eun Oh, Sang Joon Lee
doaj   +1 more source

[Adverse drug reactions of hydroxymethylglutaryl-CoA reductase inhibitors reported to agency for medicinal products and medical devices].

Lijecnicki vjesnik, 2011
Hydroxymethylglutaryl-CoA reductase inhibitors (statins) are drugs used in the treatment of chronic diseases and frequently in concomitant therapy with many other drugs. Therefore, the risk of adverse drug reactions (ADRs), especially those caused by interactions is high.
Nikica Mirosević, Skvrce, Nada, Bozina, Viola Macolić, Sarinić, Sinisa, Tomić   +3 more
openaire   +1 more source